English Polski
Vol 17, No 3 (2020)
Review paper
Published online: 2020-08-30

open access

Page views 7352
Article views/downloads 5017
Get Citation

Connect on Social Media

Connect on Social Media

Citalopram: an SSRI antidepressant that has been rediscovered

Andrzej Czernikiewicz, Tomasz Horoch
Psychiatria 2020;17(3):130-133.

Abstract

Citalopram is the most selective molecule in the class of selective serotonin reuptake inhibitors (SSRIs), except its active
enantiomer S-citalopram. It belongs to the group of antidepressant and anxiolytic drugs, which is currently the standard
in the treatment of depressive disorders and anxiety disorders with panic attacks, especially for the elderly. There is
a lower risk of adverse interactions with other drugs because citalopram is metabolized by several CYP isoenzymes.
The risk of sexual dysfunction caused by citalopram appears to be relatively smaller in comparison with other SSRIs.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Landowski J. Citalopram (cipramil) ambulatoryjnej monoterapii zespołów depresyjnych. Psychiatria Polska. 2000; 34(3): suplement.
  2. Stahl SM. Prescriber’s guide Antidepressants. Fifth edition. Cambridge University Press 2014.
  3. Bazire S. Przewodnik leków psychotropowych. Via Medica, Gdańsk 2014.
  4. Hochstrasser B, Isaksen PM, Lauritzen L, et al. Prophylactic Effect of Citalopram in Unipolar, Recurrent Depression: Placebo-Controlled Study of Maintenance Therapy . Br J Psychiatry. 2001; 178: 304–310.
  5. Klysner i wsp., Br J Psychiatry 2002; 181: 29–35; przegląd Appelberg, EBMH 2003: 6: 24.
  6. Cipriani A, Purgato M, Furukawa TA. Citalopram versus other anti-depressive agents for depression . Cochrane Database Syst Rev. 2012; 7(7): CD006534.
  7. Ou JJ, Xun GL, Wu RR, et al. Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study. Psychopharmacology (Berl). 2011; 213(2-3): 639–646.
  8. Schaffer A, Zuker E, Levitt A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. Schaffer i wsp , J Affect Disord. 2006; 96: 95–9.
  9. Perna G, Bertani A, Caldirola D, et al. A comparison of citalopram and paroxetine in the treatment of panic disorder, a randomised single blind study. Pharmacopsychiatry. 2001; 34 : 85–90.
  10. Charakterystyka Produktu Leczniczego Citaxin 20 mg, tabletki powlekane, zatw. 04.2020.
  11. Brosen K, Naranjo CA. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol. 2001; 11: 275–283.
  12. Padala PR, Padala K, Sadiq H. Urinary obstruction with citalopram and aripiprazole combination in an elderly patient. J Clin Psychopharmacol. 2006; 26: 667–678.
  13. Milne R, Goa K. Citalopram. A Review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in deppresion illness . Drugs. 1991; 41(3): 450–477.
  14. Avenoso A, Facciola G, Scordo MG. No effect of citalopram on plasma levels of clozapine, risperidone and their active metabolites in patients with chronic schizophrenia. Clin Drug Investigation . 1998; 16: 393–398.
  15. Blaschke D, Parvani AD, Huemer M. Torsade de pointes during combined treatment with rispridone and citalopram. Pharmacopsychiatry. 2007; 40(01): 294–295.
  16. Nolting A, Abramowitz W. Lack of interaction between citalopram and the CYP3A4 substrate triazolam. Pharmacother. 2000; 20: 750–755.
  17. Hall i wsp., J. Clin. Psychopharmacol. 2003; 23: 349–7).
  18. Molden E, Spigset ). [Interactions Between Metoprolol and Antidepressants]. Tidsskr Nor Laegeforen. 2011; 131: 1777–1779.
  19. Moller i wsp., J. Clin. Psychophamacol. 2001; 21: 493–9).
  20. Gram i wsp., Ther. Drug Monit. 1993; 15: 18–24).
  21. Preskorn i wsp., Br. J. Clin. Pharmacol. 1997; 44: 199–202).
  22. Sayal KS, Duncan-McConnell DA, McConnell HW. Psychotropic interactions with warfarin. Acta Psychiatr Scand. 2000; 102: 250–255.
  23. [źródło].
  24. [źródło].
  25. Cipriani A, Furukawa TA, Salanti G, et al. Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry. 2008; 69(9): 1404–1415.
  26. [źródło].